USF1 and hSET1A Mediated Epigenetic Modifications Regulate Lineage Differentiation and HoxB4 Transcription

PLoS Genetics

Volumn 9, Issue 6, 2013, Pages

  Deng, Changwang ^a   Li, Ying ^a   Liang, Shermi ^a   Cui, Kairong ^b   Salz, Tal ^a   Yang, Hui ^a   Tang, Zhanyun ^c   Gallagher, Patrick G ^d   Qiu, Yi ^a   Roeder, Robert ^c   Zhao, Keji ^b   Bungert, Jörg ^a   Huang, Suming ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; HOXB4 PROTEIN; SET1A PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL CELL; ARTICLE; AUSF1 GENE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION; CHROMATIN; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIAL HEMATOPOIETIC TRANSITION; ENZYME ACTIVITY; EPIGENETICS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HOXB4 GENE; HUMAN; HUMAN CELL; MESODERM; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HOMEODOMAIN PROTEINS; HUMANS; K562 CELLS; MESODERM; METHYLTRANSFERASES; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UPSTREAM STIMULATORY FACTORS;

EID: 84879613132     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003524     Document Type: Article

References (57)

1. Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, et al. (2006) Chromatin signatures of pluripotent cell lines. Nature cell biology 8: 532-538.
2. Christophersen NS, Helin K, (2010) Epigenetic control of embryonic stem cell fate. The Journal of experimental medicine 207: 2287-2295.
3. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
4. Pan G, Tian S, Nie J, Yang C, Ruotti V, et al. (2007) Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell stem cell 1: 299-312.
5. Zhao XD, Han X, Chew JL, Liu J, Chiu KP, et al. (2007) Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell stem cell 1: 286-298.
6. Sharov AA, Ko MS, (2007) Human ES cell profiling broadens the reach of bivalent domains. Cell stem cell 1: 237-238.
7. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
8. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, et al. (2008) EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Molecular cell 32: 491-502.
9. Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, et al. (2009) Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139: 1303-1314.
10. Cui K, Zang C, Roh TY, Schones DE, Childs RW, et al. (2009) Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell stem cell 4: 80-93.
11. Ang YS, Tsai SY, Lee DF, Monk J, Su J, et al. (2011) Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145: 183-197.
12. Jiang H, Shukla A, Wang X, Chen WY, Bernstein BE, et al. (2011) Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144: 513-525.
13. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, et al. (2005) WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 121: 859-872.
14. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, et al. (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nature structural & molecular biology 13: 713-719.
15. Steward MM, Lee JS, O'Donovan A, Wyatt M, Bernstein BE, et al. (2006) Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nature structural & molecular biology 13: 852-854.
16. Ernst P, Fisher JK, Avery W, Wade S, Foy D, et al. (2004) Definitive hematopoiesis requires the mixed-lineage leukemia gene. Developmental cell 6: 437-443.
17. Wang P, Lin C, Smith ER, Guo H, Sanderson BW, et al. (2009) Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Molecular and cellular biology 29: 6074-6085.
18. Lee J, Saha PK, Yang QH, Lee S, Park JY, et al. (2008) Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 105: 19229-19234.
19. Soshnikova N, Duboule D, (2009) Epigenetic temporal control of mouse Hox genes in vivo. Science 324: 1320-1323.
20. Pilat S, Carotta S, Schiedlmeier B, Kamino K, Mairhofer A, et al. (2005) HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America 102: 12101-12106.
21. Schiedlmeier B, Santos AC, Ribeiro A, Moncaut N, Lesinski D, et al. (2007) HOXB4's road map to stem cell expansion. Proceedings of the National Academy of Sciences of the United States of America 104: 16952-16957.
22. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ, (2005) Embryonic stem cell-derived hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America 102: 19081-19086.
23. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, et al. (1995) Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes & development 9: 1753-1765.
24. Antonchuk J, Sauvageau G, Humphries RK, (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109: 39-45.
25. Kyba M, Perlingeiro RC, Daley GQ, (2002) HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109: 29-37.
26. Liu HC, Shih LY, May Chen MJ, Wang CC, Yeh TC, et al. (2011) Expression of HOXB genes is significantly different in acute myeloid leukemia with a partial tandem duplication of MLL vs. a MLL translocation: a cross-laboratory study. Cancer genetics 204: 252-259.
27. Giannola DM, Shlomchik WD, Jegathesan M, Liebowitz D, Abrams CS, et al. (2000) Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2. The Journal of experimental medicine 192: 1479-1490.
28. Kirito K, Fox N, Kaushansky K, (2003) Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 102: 3172-3178.
29. Zhu J, Zhang Y, Joe GJ, Pompetti R, Emerson SG, (2005) NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal. Proceedings of the National Academy of Sciences of the United States of America 102: 11728-11733.
30. Zhu J, Giannola DM, Zhang Y, Rivera AJ, Emerson SG, (2003) NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4. Blood 102: 2420-2427.
31. Li X, Wang S, Li Y, Deng C, Steiner LA, et al. (2011) Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 118: 1386-1394.
32. Li X, Hu X, Patel B, Zhou Z, Liang S, et al. (2010) H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation. Blood 115: 2028-2037.
33. Clouaire T, Webb S, Skene P, Illingworth R, Kerr A, et al. (2012) Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes & development 26: 1714-1728.
34. Liang SY, Moghimi B, Crusselle-Davis VJ, Lin IJ, Rosenberg MH, et al. (2009) Defective erythropoiesis in transgenic mice expressing dominant-negative upstream stimulatory factor. Molecular and cellular biology 29: 5900-5910.
35. McKinney-Freeman SL, Naveiras O, Yates F, Loewer S, Philitas M, et al. (2009) Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood 114: 268-278.
36. Oshima M, Endoh M, Endo TA, Toyoda T, Nakajima-Takagi Y, et al. (2011) Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood 117: e142-150.
37. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, et al. (2009) The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457: 892-895.
38. Bee T, Swiers G, Muroi S, Pozner A, Nottingham W, et al. (2010) Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 115: 3042-3050.
39. Orkin SH, Zon LI, (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132: 631-644.
40. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G, (1998) A common precursor for hematopoietic and endothelial cells. Development 125: 725-732.
41. Lengerke C, Schmitt S, Bowman TV, Jang IH, Maouche-Chretien L, et al. (2008) BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell stem cell 2: 72-82.
42. Murry CE, Keller G, (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680.
43. Iacovino M, Chong D, Szatmari I, Hartweck L, Rux D, et al. (2011) HoxA3 is an apical regulator of haemogenic endothelium. Nature cell biology 13: 72-78.
44. Kinder SJ, Tsang TE, Quinlan GA, Hadjantonakis AK, Nagy A, et al. (1999) The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development 126: 4691-4701.
45. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, et al. (2003) Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130: 4217-4227.
46. Huang S, Li X, Yusufzai TM, Qiu Y, Felsenfeld G, (2007) USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Molecular and cellular biology 27: 7991-8002.
47. van Ingen H, van Schaik FM, Wienk H, Ballering J, Rehmann H, et al. (2008) Structural insight into the recognition of the H3K4me3 mark by the TFIID subunit TAF3. Structure 16: 1245-1256.
48. Lee JH, Tate CM, You JS, Skalnik DG, (2007) Identification and characterization of the human Set1B histone H3-Lys4 methyltransferase complex. J Biol Chem 282: 13419-13428.
49. Liu Z, Scannell DR, Eisen MB, Tjian R, (2011) Control of embryonic stem cell lineage commitment by core promoter factor, TAF3. Cell 146: 720-731.
50. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, et al. (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639-5649.
51. Cho YW, Hong T, Hong S, Guo H, Yu H, et al. (2007) PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 282: 20395-20406.
52. West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G, (2004) Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Molecular cell 16: 453-463.
53. Brun AC, Bjornsson JM, Magnusson M, Larsson N, Leveen P, et al. (2004) Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 103: 4126-4133.
54. Bjornsson JM, Larsson N, Brun AC, Magnusson M, Andersson E, et al. (2003) Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Molecular and cellular biology 23: 3872-3883.
55. Magnusson M, Brun AC, Lawrence HJ, Karlsson S, (2007) Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects. Experimental hematology 35: 1421-1428.
56. Shen J, Qu CK, (2008) In vitro hematopoietic differentiation of murine embryonic stem cells. Methods in molecular biology 430: 103-118.
57. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.